Get started
Surmodics, Inc.Surmodics, Inc.Surmodics, Inc.

Surmodics, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

SRDX chart

Key stats

Market capitalization
‪377.54 M‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
68.33
Basic EPS (TTM)
0.39USD
Net income
‪−1.54 M‬USD
Revenue
‪132.58 M‬USD
Shares float
‪13.63 M‬
Beta (1Y)
1.18

About Surmodics, Inc.

Sector
Health Technology
Industry
Medical Specialties
CEO
Gary R. Maharaj
Website
surmodics.com
Headquarters
Eden Prairie
Employees (FY)
376
Founded
1979
ISIN
US8688731004
FIGI
BBG000BZ2QG2
Surmodics, Inc. engages in the provision of surface modification technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays. It also develops and commercializes medical devices that are designed to address unmet clinical needs and engineered to the most demanding requirements. The firm operates through the following segments: Medical Device, In Vitro Diagnostics, and Corporate. The Medical Device segment designs, develops, and manufactures vascular interventional medical devices, surface modification coating technologies, as well as drug-delivery coating technologies. The In Vitro Diagnostics segment is composed of component products and technologies for diagnostic test kits and biomedical research applications. The company was founded in June 1979 and is headquartered in Eden Prairie, MN.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of SRDX is 26.39 USD — it has decreased by 0.49% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Surmodics, Inc. stocks are traded under the ticker SRDX.
Surmodics, Inc. is going to release the next earnings report on May 1, 2024. Keep track of upcoming events with our Earnings Calendar.
SRDX stock is 2.01% volatile and has beta coefficient of 1.18. Check out the list of the most volatile stocks — is Surmodics, Inc. there?
One year price forecast for Surmodics, Inc. has a max estimate of 75.00 USD and a min estimate of 44.00 USD.
SRDX earnings for the last quarter are 0.53 USD whereas the estimation was 0.16 USD which accounts for 236.51% surprise. Estimated earnings for the next quarter are −0.33 USD. See more details about Surmodics, Inc. earnings.
Surmodics, Inc. revenue for the last quarter amounts to ‪27.97 M‬ USD despite the estimated figure of ‪26.27 M‬ USD. In the next quarter revenue is expected to reach ‪29.64 M‬ USD.
Yes, you can track Surmodics, Inc. financials in yearly and quarterly reports right on TradingView.
SRDX stock has fallen by 4.35% compared to the previous week, the month change is a 3.93% fall, over the last year Surmodics, Inc. has showed a 14.74% increase.
SRDX net income for the last quarter is ‪−786.00 K‬ USD, while the quarter before that showed ‪6.69 M‬ USD of net income which accounts for −111.74% change. Track more Surmodics, Inc. financial stats to get the full picture.
Today Surmodics, Inc. has the market capitalization of ‪375.69 M‬, it has increased by 1.93% over the last week.
No, SRDX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, SRDX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Surmodics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
SRDX reached its all-time high on Sep 4, 2018 with the price of 82.35 USD, and its all-time low was 2.50 USD and was reached on Oct 5, 1998.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 376.00 employees. See our rating of the largest employees — is Surmodics, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Surmodics, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Surmodics, Inc. stock shows the strong sell signal. See more of Surmodics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Surmodics, Inc. future price: according to them, SRDX price has a max estimate of 75.00 USD and a min estimate of 44.00 USD. Read a more detailed Surmodics, Inc. forecast: see what analysts think of Surmodics, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Surmodics, Inc. EBITDA is ‪21.92 M‬ USD, and current EBITDA margin is 11.15%. See more stats in Surmodics, Inc. financial statements.